OWP
GILD icon

Obermeyer Wealth Partners’s Gilead Sciences GILD Stock Holding History

Obermeyer Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
2,894
-49
-2% -$6.46K 0.02% 218
2026
Q1 		$410K Sell
2,943
-11
-0.4% -$1.54K 0.02% 195
2025
Q4 		$363K Buy
2,954
+11
+0.4% +$1.34K 0.02% 211
2025
Q3 		$327K Sell
2,943
-22
-0.7% -$2.5K 0.02% 219
2025
Q2 		$329K Buy
2,965
+71
+2% +$7.56K 0.02% 208
2025
Q1 		$324K Buy
+2,894
New +$299K 0.02% 194
2020
Q3 		– Sell
-3,836
Closed -$295K – 148
2020
Q2 		$295K Sell
3,836
-1,029
-21% -$78.9K 0.02% 108
2020
Q1 		$364K Sell
4,865
-1,574
-24% -$109K 0.04% 80
2019
Q4 		$418K Sell
6,439
-310
-5% -$20.2K 0.04% 83
2019
Q3 		$428K Sell
6,749
-881
-12% -$57.6K 0.04% 80
2019
Q2 		$515K Sell
7,630
-210
-3% -$13.8K 0.05% 77
2019
Q1 		$510K Sell
7,840
-1,290
-14% -$85.7K 0.05% 75
2018
Q4 		$571K Sell
9,130
-12,935
-59% -$904K 0.06% 68
2018
Q3 		$1.7M Sell
22,065
-2,915
-12% -$220K 0.14% 46
2018
Q2 		$1.77M Sell
24,980
-191,473
-88% -$13.5M 0.16% 42
2018
Q1 		$16.3M Sell
216,453
-48,039
-18% -$3.82M 1.48% 27
2017
Q4 		$18.9M Sell
264,492
-45,593
-15% -$3.46M 1.65% 23
2017
Q3 		$25.1M Sell
310,085
-6,619
-2% -$506K 2.18% 24
2017
Q2 		$22.4M Sell
316,704
-30,045
-9% -$2M 1.99% 24
2017
Q1 		$23.6M Buy
346,749
+6,791
+2% +$478K 2.17% 23
2016
Q4 		$24.3M Sell
339,958
-24,068
-7% -$1.79M 2.33% 20
2016
Q3 		$28.8M Sell
364,026
-4,328
-1% -$352K 2.76% 16
2016
Q2 		$30.7M Buy
+368,354
New +$32.7M 3.06% 11
2013
Q3 		– Sell
-1,400
Closed -$72K – 157
2013
Q2 		$72K Buy
+1,400
New +$73K 0.02% 97

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Obermeyer Wealth Partners's GILD Position: Q2 2026 in Review

Obermeyer Wealth Partners reduced its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, selling an estimated $6.46K and leaving 2,894 shares worth $366K. The position accounts for 0.02% of the portfolio, ranked #218.

Obermeyer Wealth Partners first reported a position in GILD in Q2 2013 and has held it in 24 quarters since. The position peaked at $30.7M in Q2 2016. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Obermeyer Wealth Partners held 2,894 shares of Gilead Sciences worth $366K as of Q2 2026.
  • Obermeyer Wealth Partners sold 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
  • Gilead Sciences made up 0.02% of Obermeyer Wealth Partners's portfolio in Q2 2026, its #218 holding.
  • Obermeyer Wealth Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 24 quarters since.
  • Obermeyer Wealth Partners's Gilead Sciences position peaked at $30.7M in Q2 2016.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.